The following represents disclosure information provided by authors of this abstract. The program committee has reviewed all presenting author disclosure reports, identified potential conflicts of interest, and implemented strategies to manage those areas of conflict, where appropriate. All relationships are considered compensated. Relationships are self-held unless otherwise noted. I = Immediate Family Member, Inst = My Institution
 
Open Payments is a public database containing information reported by companies about payments made to US-licensed physicians (Open Payments)
Real-life results from the prospective QoliXane trial of the platform for outcome, quality of life, and translational research on pancreatic cancer (PARAGON) registry.
 
Salah-Eddin Al-Batran
Stock and Other Ownership Interests - IKF Klinische Krebsforschung
Consulting or Advisory Role - Bristol-Myers Squibb; Celgene; Lilly; Merck; Merck Sharp & Dohme; Nordic Bioscience; Roche
Speakers' Bureau - AIO gGmbH; Celgene; Forum für Medizinische Fortbildung; Lilly; MCI group; Nordic Bioscience
Research Funding - Celgene; Federal Ministry of Education and Research; German Cancer Aid; German Research Foundation; Hospira; Lilly; Medac; Merck; Roche; Sanofi; Vifor Pharma
 
Ralf Dieter Hofheinz
Honoraria - Amgen; Bristol-Myers Squibb; Lilly; Medac; Merck Serono; MSD; Roche; Sanofi
Consulting or Advisory Role - Amgen; Bristol-Myers Squibb; Merck Serono; MSD; Roche; Sanofi
Speakers' Bureau - Amgen; Bristol-Myers Squibb; Lilly; Merck; MSD; Roche; Sanofi; SERVIER
Research Funding - German Cancer Aid (Inst); Medac (Inst); Sanofi (Inst)
 
Alexander Reichart
No Relationships to Disclose
 
Claudia Pauligk
No Relationships to Disclose
 
Rudolf Schlag
No Relationships to Disclose
 
Gabriele Margareta Siegler
Honoraria - Eisai; Janssen-Cilag; medizinwelten services GmbH; Roche; Shire
Research Funding - Beigene (Inst); Celgene (Inst); Isofol Medical (Inst); MOLOGEN (Inst); Novartis (Inst); Nutricia (Inst); Roche (Inst); Roche/Genentech (Inst); Sanofi (Inst); Sanofi (Inst); Servier (Inst)
Travel, Accommodations, Expenses - Lilly
 
Heinz-Gert Hoeffkes
No Relationships to Disclose
 
Wolfgang Blau
No Relationships to Disclose
 
Nils Homann
No Relationships to Disclose
 
Jorg Trojan
No Relationships to Disclose
 
Oliver Waidmann
Honoraria - Amgen; Bayer; Bristol-Myers Squibb; Celgene; Eisai; Falk Foundation; Ipsen; Merck; MSD; Novartis; Roche; Servier; Shire
Consulting or Advisory Role - Bayer; Bristol-Myers Squibb; Celgene; Eisai; Falk Foundation; Ipsen; Merck Serono; MSD; Novartis; Roche; Servier; Shire
Research Funding - Merck Serono
Travel, Accommodations, Expenses - Abbvie; Bristol-Myers Squibb; Ipsen; Medac; Merck Serono
 
Daniel Pink
Employment - Helios Kliniken GmbH
Consulting or Advisory Role - Clinigen Group (Inst); Lilly (Inst); Roche (Inst)
Research Funding - Clinigen Group (Inst); Lilly (Inst); Novartis (Inst); PharmaMar (Inst); Roche (Inst)
 
Helmut Messmann
No Relationships to Disclose
 
Volker Kunzmann
No Relationships to Disclose
 
Arndt Vogel
Honoraria - Amgen; Bristol-Myers Squibb; Delcath Systems; Ipsen; Janssen; Lilly; MSD; Novartis; Pierre Fabre; Roche; Sanofi
Consulting or Advisory Role - Amgen; AstraZeneca; Baxalta; Bayer; BTG; Eisai; IPSEN; Lilly; Novartis; Pierre Fabre; Roche
Research Funding - Novartis
Travel, Accommodations, Expenses - Bayer; Ipsen; Roche
 
Thomas Jens Ettrich
Consulting or Advisory Role - Bayer; Bayer; Bristol-Myers Squibb; Bristol-Myers Squibb; Eisai; Lilly; Merck Serono; MSD; MSD; Roche; Roche; Roche; Roche; Sanofi; Sanofi; Sanofi/Aventis
Research Funding - Baxalta/Shire
Travel, Accommodations, Expenses - Ipsen; Ipsen
 
Caroline Schoenherr
Honoraria - Celgene
 
Marina Schaaf
No Relationships to Disclose
 
Gerrit zur Hausen
No Relationships to Disclose
 
Thorsten Oliver Goetze
Consulting or Advisory Role - Bayer; Lilly; MSD Oncology; Roche; SERVIER
Speakers' Bureau - Lilly
Research Funding - Deutsche Forschungsgemeinschaft; Gemeinsamer Bundesausschuss